Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

5’-CTG CCA CGT TCT CCT GC-(2’ methoxy)A-(2’ methoxy)C-(2’ methoxy)C-3’

EU orphan designation number: EU/3/04/203
Active ingredient: 5’-CTG CCA CGT TCT CCT GC-(2’ methoxy)A-(2’ methoxy)C-(2’ methoxy)C-3’
Indication: Treatment of myasthenia gravis
Sponsor: PPD Global Ltd
Granta Park, Great Abington, Cambridge, Cambridgeshire CB21 6GQ, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
24/06/2004 Orphan designation EMEA/OD/008/04 (2004)2310 of 21/06/2004
15/02/2017 Removal of orphan designation from Community Register